• Medicine
  • Published in Acta poloniae pharmaceutica 2017

MONITORING OF SYNERGISTIC ENHANCEMENT OF CAFFEIC ACID ON ESCHERICHIA COLI K-12 RECA::GFP STRAIN TREATED WITH DACARBAZINE.

@article{Matejczyk2017MONITORINGOS,
  title={MONITORING OF SYNERGISTIC ENHANCEMENT OF CAFFEIC ACID ON ESCHERICHIA COLI K-12 RECA::GFP STRAIN TREATED WITH DACARBAZINE.},
  author={Marzena Matejczyk and Renata Świsłocka and Monika Kalinowska and Grzegorz Swidersk and Wlodzimierz Lewandowsk and Agata Jablonska-Trypuo},
  journal={Acta poloniae pharmaceutica},
  year={2017},
  volume={74 3},
  pages={
          809-816
        }
}
Caffeic acid and its derivatives because of its biological activities, including antioxidants, antithrombosis, antihypertensive, antifibrosis, antiviral, and anti-tumor properties are good candidates as adjuvants in anticancer therapy. The aim of this study was the examination of cyto- and genotoxic effect of caffeic acid on Escherichia coli K-12 recA::gfp strain treated with dacarbazine. Obtained results indicate that dacarbazine and caffeic acid influenced the reactivity of recA promoter and… CONTINUE READING

Citations

Publications citing this paper.

Production of caffeoylmalic acid from glucose in engineered Escherichia coli

  • Biotechnology Letters
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND